Intelligent Bio Solutions Inc
(INBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 872 | 575 | 824 | 917 | 796 |
| Cost of Goods | 526 | -88 | 645 | 565 | 564 |
| Gross Profit | 347 | 662 | 179 | 353 | 232 |
| Operating Expenses | 3,598 | 3,386 | 3,778 | 2,909 | 3,323 |
| Operating Income | -2,725 | -2,812 | -2,954 | -1,991 | -2,526 |
| Interest Expense | 22 | 55 | 43 | 33 | 37 |
| Other Income | 53 | 71 | 10 | 48 | 131 |
| Pre-tax Income | -2,695 | -2,795 | -2,987 | -1,976 | -2,432 |
| Net Income Continuous | -2,695 | -2,795 | -2,987 | -1,976 | -2,432 |
| Minority Interests | -9 | -11 | -9 | -7 | -7 |
| Net Income | $-2,686 | $-2,784 | $-2,978 | $-1,970 | $-2,425 |
| EPS Basic Total Ops | -7.00 | 96.00 | -14.30 | -20.70 | -124.80 |
| EPS Basic Continuous Ops | -7.07 | 96.45 | -14.36 | -20.81 | -125.25 |
| EPS Diluted Total Ops | -7.00 | 96.00 | -14.30 | -20.70 | -124.80 |
| EPS Diluted Continuous Ops | -7.07 | 96.45 | -14.36 | -20.81 | -125.25 |
| EPS Diluted Before Non-Recurring Items | -7.00 | N/A | -14.30 | -20.70 | N/A |
| EBITDA(a) | $-2,484 | $-2,584 | $-2,686 | $-1,760 | $-2,279 |